Bioavallability is a measure of the fraction of the administered dose that reaches the systemic circulation.

Absolute bioavailability is the fraction of the total dose that reaches the systemic circulation. It can have values between zero when the drug is not absorbed at all to 1 when all the administered dose reaches the systemic circulation. The absolute bioavailability can be expressed in terms of percentage (0% - 100%).

The relative bioavailability is the bioavailability of a drug product relative to the bioavailability of another drug product (reference standard preparation). The relative bioavailability can have any value above zero. It can be more than one when the product under investigation has bioavailability higher than that of the reference standard.

It is the volume of the plasma or the blood that is completely cleared from the drug per unit time by the kidney. It has units of volume/time.

The renal clearance cannot exceed the CL_T. However it can be equal to the CL_T when the drug is excreted completely unchanged by the kidney.

The renal clearance can be determined from the renal excretion rate over a short interval and the average plasma concentration during this interval.

The total body clearance is the volume of the plasma or blood which is completely cleared from the drug per unit time. It has units of volume/time.

The CL_T for a drug is constant within a patient (dose and concentration independent) when the elimination processes follow first-order kinetics.

The total body clearance is a measure of the efficiency of all eliminating organs in eliminating the drug and it is the sum of all organ clearances (i.e. CL_T is the sum of the renal clearance, hepatic clearance and all other organ clearances).

The elimination rate constant and the half life (the dependent pharmacokinetic parameters) are dependent on (is determined from) the total body clearance and the volume of distribution (the independent pharmacokinetic parameters).